Production (Stage)
Serina Therapeutics, Inc.
SER
$6.00
$0.254.35%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -75.66% | -294.33% | 477.01% | 97.51% | -1,528.64% |
| Total Depreciation and Amortization | -69.64% | 0.00% | -1.75% | 128.00% | 316.67% |
| Total Amortization of Deferred Charges | -- | 0.00% | -97.39% | 1,295.45% | -- |
| Total Other Non-Cash Items | 101.09% | 67.63% | -67.36% | -125.00% | 1,974.05% |
| Change in Net Operating Assets | 364.53% | -118.24% | 119.71% | -994.39% | 314.00% |
| Cash from Operations | 5.82% | -54.93% | 63.02% | -407.86% | -1,403.31% |
| Capital Expenditure | -- | -66.67% | -- | 100.00% | 80.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -66.67% | -- | 100.00% | 80.00% |
| Total Debt Issued | -- | 1,275.00% | -98.48% | -78.13% | -- |
| Total Debt Repaid | -- | 87.50% | 94.52% | -1,023.08% | 0.00% |
| Issuance of Common Stock | -99.98% | 5,623.26% | -98.28% | 124,600.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Financing | -2.27% | 5,750.00% | -98.40% | 96.74% | 21,084.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.16% | 115.18% | -8.97% | -332.37% | 2,892.11% |